14-73953424-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182476.3(COQ6):​c.164-11C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.207 in 1,589,904 control chromosomes in the GnomAD database, including 32,550 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4676 hom., cov: 32)
Exomes 𝑓: 0.20 ( 27874 hom. )

Consequence

COQ6
NM_182476.3 intron

Scores

2
Splicing: ADA: 0.00001369
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.578

Publications

8 publications found
Variant links:
Genes affected
COQ6 (HGNC:20233): (coenzyme Q6, monooxygenase) The protein encoded by this gene belongs to the ubiH/COQ6 family. It is an evolutionarily conserved monooxygenase required for the biosynthesis of coenzyme Q10 (or ubiquinone), which is an essential component of the mitochondrial electron transport chain, and one of the most potent lipophilic antioxidants implicated in the protection of cell damage by reactive oxygen species. Knockdown of this gene in mouse and zebrafish results in decreased growth due to increased apoptosis. Mutations in this gene are associated with autosomal recessive coenzyme Q10 deficiency-6 (COQ10D6), which manifests as nephrotic syndrome with sensorineural deafness. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jun 2012]
COQ6 Gene-Disease associations (from GenCC):
  • familial steroid-resistant nephrotic syndrome with sensorineural deafness
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • SMARCB1-related schwannomatosis
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 14-73953424-C-T is Benign according to our data. Variant chr14-73953424-C-T is described in ClinVar as Benign. ClinVar VariationId is 136983.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.383 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COQ6NM_182476.3 linkc.164-11C>T intron_variant Intron 1 of 11 ENST00000334571.7 NP_872282.1 Q9Y2Z9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COQ6ENST00000334571.7 linkc.164-11C>T intron_variant Intron 1 of 11 1 NM_182476.3 ENSP00000333946.2 Q9Y2Z9-1

Frequencies

GnomAD3 genomes
AF:
0.239
AC:
36317
AN:
151854
Hom.:
4666
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.314
Gnomad AMI
AF:
0.235
Gnomad AMR
AF:
0.257
Gnomad ASJ
AF:
0.190
Gnomad EAS
AF:
0.397
Gnomad SAS
AF:
0.271
Gnomad FIN
AF:
0.157
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.192
Gnomad OTH
AF:
0.210
GnomAD2 exomes
AF:
0.233
AC:
57159
AN:
245772
AF XY:
0.226
show subpopulations
Gnomad AFR exome
AF:
0.303
Gnomad AMR exome
AF:
0.335
Gnomad ASJ exome
AF:
0.172
Gnomad EAS exome
AF:
0.388
Gnomad FIN exome
AF:
0.159
Gnomad NFE exome
AF:
0.185
Gnomad OTH exome
AF:
0.202
GnomAD4 exome
AF:
0.204
AC:
292942
AN:
1437936
Hom.:
27874
Cov.:
30
AF XY:
0.204
AC XY:
145976
AN XY:
716320
show subpopulations
African (AFR)
AF:
0.305
AC:
9890
AN:
32476
American (AMR)
AF:
0.335
AC:
14580
AN:
43488
Ashkenazi Jewish (ASJ)
AF:
0.175
AC:
4528
AN:
25930
East Asian (EAS)
AF:
0.378
AC:
14773
AN:
39124
South Asian (SAS)
AF:
0.252
AC:
21325
AN:
84734
European-Finnish (FIN)
AF:
0.165
AC:
8789
AN:
53254
Middle Eastern (MID)
AF:
0.150
AC:
851
AN:
5686
European-Non Finnish (NFE)
AF:
0.188
AC:
205915
AN:
1093796
Other (OTH)
AF:
0.207
AC:
12291
AN:
59448
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.418
Heterozygous variant carriers
0
10987
21974
32961
43948
54935
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7602
15204
22806
30408
38010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.239
AC:
36368
AN:
151968
Hom.:
4676
Cov.:
32
AF XY:
0.238
AC XY:
17695
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.314
AC:
13010
AN:
41444
American (AMR)
AF:
0.256
AC:
3907
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.190
AC:
659
AN:
3466
East Asian (EAS)
AF:
0.397
AC:
2054
AN:
5172
South Asian (SAS)
AF:
0.273
AC:
1312
AN:
4812
European-Finnish (FIN)
AF:
0.157
AC:
1660
AN:
10562
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.192
AC:
13062
AN:
67960
Other (OTH)
AF:
0.212
AC:
447
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1321
2642
3962
5283
6604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0759
Hom.:
211
Bravo
AF:
0.256

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 45% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 42. Only high quality variants are reported. -

Sep 19, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.21
DANN
Benign
0.55
PhyloP100
-0.58
Mutation Taster
=52/48
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000014
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3213692; hg19: chr14-74420127; COSMIC: COSV53178908; COSMIC: COSV53178908; API